Molecular testing for lung adenocarcinoma: Is it time to adopt a "plasma-first" approach?
Maisam Makarem1, Natasha B Leighl1
1Division of Medical Oncology, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada.
Cancer
|May 5, 2020
Abstract
No abstract available in PubMed .
More Related Videos
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.5K
08:14MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
16.1K
